Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end point.
Decensi A, Torrisi R, Bruno S, Costantini M, Curotto A, Nicolò G, Malcangi B, Baglietto L, Bruttini GP, Gatteschi B, Rondanina G, Varaldo M, Perloff M, Malone WF, Bruzzi P.
Decensi A, et al. Among authors: nicolo g.
Cancer Epidemiol Biomarkers Prev. 2000 Oct;9(10):1071-8.
Cancer Epidemiol Biomarkers Prev. 2000.
PMID: 11045790
Clinical Trial.